The noninvasive diagnosis of allograft rejection after heart transplantation may be on the horizon, according to findings ...

After years of type 2 diabetes, red blood cells may quietly turn against the heart—offering a new clue for spotting danger ...

Victor Ambros receives funding from the U.S. National Institutes of Health. The Conversation Weekly podcast caught up with Victor Ambros from his lab at the UMass Chan Medical School to learn more ...

MicroRNAs are small evolutionarily conserved nucleotide sequences that regulate gene expression by interfering with mRNA translation and stability. MicroRNA-deficient CD4 + T cells show impaired ...

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Gary Ruvkun is used to getting awards — but for him, the Nobel Prize ...

The global microRNA market is projected to reach USD 3.22 billion by 2027, according to the Ambulance Services Market Report provided by Report Ocean. This report offers a comprehensive analysis of ...

Victor Ambros (l) and Gary Ruvkun (r) share the 2024 Nobel Prize in Physiology or Medicine Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their ...

The 2024 Nobel prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of tiny pieces of RNA, called microRNAs, that play a key role in regulating gene ...